BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36136066)

  • 1. Molecular Mimicry between SARS-CoV-2 and Human Endocrinocytes: A Prerequisite of Post-COVID-19 Endocrine Autoimmunity?
    Churilov LP; Normatov MG; Utekhin VJ
    Pathophysiology; 2022 Aug; 29(3):486-494. PubMed ID: 36136066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-COVID Endocrine Disorders: Putative Role of Molecular Mimicry and Some Pathomorphological Correlates.
    Normatov MG; Karev VE; Kolobov AV; Mayevskaya VA; Ryabkova VA; Utekhin VJ; Churilov LP
    Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shared Pathogenicity Features and Sequences between EBV, SARS-CoV-2, and HLA Class I Molecule-binding Motifs with a Potential Role in Autoimmunity.
    Adiguzel Y; Mahroum N; Muller S; Blank M; Halpert G; Shoenfeld Y
    Clin Rev Allergy Immunol; 2023 Aug; 65(2):206-230. PubMed ID: 37505416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mimicry between SARS-CoV-2 and the female reproductive system.
    Dotan A; Kanduc D; Muller S; Makatsariya A; Shoenfeld Y
    Am J Reprod Immunol; 2021 Dec; 86(6):e13494. PubMed ID: 34407240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human molecular chaperones share with SARS-CoV-2 antigenic epitopes potentially capable of eliciting autoimmunity against endothelial cells: possible role of molecular mimicry in COVID-19.
    Marino Gammazza A; Légaré S; Lo Bosco G; Fucarino A; Angileri F; Conway de Macario E; Macario AJ; Cappello F
    Cell Stress Chaperones; 2020 Sep; 25(5):737-741. PubMed ID: 32754823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Autoimmunity Resulting from Molecular Mimicry between SARS-CoV-2 Spike and Human Proteins.
    Nunez-Castilla J; Stebliankin V; Baral P; Balbin CA; Sobhan M; Cickovski T; Mondal AM; Narasimhan G; Chapagain P; Mathee K; Siltberg-Liberles J
    Viruses; 2022 Jun; 14(7):. PubMed ID: 35891400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From Anti-SARS-CoV-2 Immune Response to the Cytokine Storm via Molecular Mimicry.
    Kanduc D
    Antibodies (Basel); 2021 Sep; 10(4):. PubMed ID: 34698069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mimicry, hyperactive immune system, and SARS-COV-2 are three prerequisites of the autoimmune disease triangle following COVID-19 infection.
    Vahabi M; Ghazanfari T; Sepehrnia S
    Int Immunopharmacol; 2022 Nov; 112():109183. PubMed ID: 36182877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Untangling COVID-19 and autoimmunity: Identification of plausible targets suggests multi organ involvement.
    Mohkhedkar M; Venigalla SSK; Janakiraman V
    Mol Immunol; 2021 Sep; 137():105-113. PubMed ID: 34242919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases.
    Vojdani A; Vojdani E; Kharrazian D
    Front Immunol; 2020; 11():617089. PubMed ID: 33584709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to SARS-CoV-2 and Infantile Diseases.
    Kanduc D
    Glob Med Genet; 2023 Jun; 10(2):72-78. PubMed ID: 37144240
    [No Abstract]   [Full Text] [Related]  

  • 12. Covid-19, heat shock proteins, and autoimmune bullous diseases: a potential link deserving further attention.
    Kasperkiewicz M
    Cell Stress Chaperones; 2021 Jan; 26(1):1-2. PubMed ID: 33196989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From Anti-SARS-CoV-2 Immune Responses to COVID-19 via Molecular Mimicry.
    Kanduc D
    Antibodies (Basel); 2020 Jul; 9(3):. PubMed ID: 32708525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmunity against Nucleus Ambiguous Is Putatively Possible in Both Long-COVID-19 and Vaccinated Subjects: Scientific Evidence and Working Hypothesis.
    D'Anna SE; Vitale AM; D'Amico G; Caruso Bavisotto C; Ambrosino P; Cappello F; Maniscalco M; Marino Gammazza A
    Biology (Basel); 2024 May; 13(6):. PubMed ID: 38927239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Immune Response to Cancer Onset via Molecular Mimicry and Cross-Reactivity.
    Kanduc D
    Glob Med Genet; 2021 Dec; 8(4):176-182. PubMed ID: 34877576
    [No Abstract]   [Full Text] [Related]  

  • 16. SARS-CoV-2 infection as a trigger of autoimmune response.
    Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R
    Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Proteome Harbors Peptides Which Are Able to Trigger Autoimmunity Responses: Implications for Infection, Vaccination, and Population Coverage.
    Karami Fath M; Jahangiri A; Ganji M; Sefid F; Payandeh Z; Hashemi ZS; Pourzardosht N; Hessami A; Mard-Soltani M; Zakeri A; Rahbar MR; Khalili S
    Front Immunol; 2021; 12():705772. PubMed ID: 34447375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporating the Molecular Mimicry of Environmental Antigens into the Causality of Autoimmune Hepatitis.
    Czaja AJ
    Dig Dis Sci; 2023 Jul; 68(7):2824-2842. PubMed ID: 37160542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 and human retroelements: a case for molecular mimicry?
    Koch BF
    BMC Genom Data; 2022 Apr; 23(1):27. PubMed ID: 35395708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mimicry and autoimmunity in the time of COVID-19.
    Rojas M; Herrán M; Ramírez-Santana C; Leung PSC; Anaya JM; Ridgway WM; Gershwin ME
    J Autoimmun; 2023 Sep; 139():103070. PubMed ID: 37390745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.